Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Acadia Pharmaceuticals Inc (ACAD)

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
Great Point Partners

Jeffrey Jay And David Kroin

1,500,000 $40,095,000 -25% 4.45%
2.
Ghost Tree Capital

Ken Greenberg And David Kim

750,000 $20,048 -17% 4.19%
3.
Palo Alto Investors

William Leland Edwards

2,308,803 $61,714 +3% 3%
4.
Opaleye Management

James A. Silverman

200,000 $5,346 1.62%
5.
VenBio Select Advisor

Kurt Von Emster

1,325,000 $35,417 1.22%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$40.00 1,494,025 Large Shareholder, Director 37,470,965 2019-09-20 Filing
$40.00 68,475 Large Shareholder, Director 3,383,621 2019-09-20 Filing
$17.00 11,178,823 Large Shareholder, Director 35,976,940 2018-11-30 Filing
$17.00 585,882 Large Shareholder, Director 3,736,902 2018-11-30 Filing
$19.09 131,007 Large Shareholder, Director 24,798,117 2018-09-20 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$40.19 120,208 Officer, Director 0 2019-10-10 Filing
$40.00 29,792 Officer, Director 0 2019-10-09 Filing
$41.18 4,645 Officer 0 2019-09-11 Filing
$39.49 28,467 Officer 4,645 2019-09-09 Filing
$38.39 400 Director 0 2019-09-09 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 15,000 $540 0.05%
2. 492 $18 0.01%
3. 0 $0 0%
4. 300 $11 0%
5. 880 $32 0%
News See All